Using an shRNA screen selectively targeting genes involved in metabolism in BRAFV600E and BRAF wild‐type melanoma cell lines, HMG‐CoA lyase (HMGCL) was identified as a possible SL partner to BRAFV600E (Kang et al., 2015). Here, HMGCL is linked to melanoma.